Peng Haoyun, CEO of Sandoz China, said that the company would like to reinforce communication with Chongqing's pharmaceutical enterprises and boost local medical industry.
The Switzerland-based Novatis is a leading healthcare solutions provider in the world, and Sandoz, its wholly owned subsidiary, has eight research and development centers around the globe, with its products covering 90 percent of the world's population.

More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index